Clinical-stage company developing novel oral immunotherapies for treatment of a broad spectrum of food allergies.
Alladapt Immunotherapeutics
Immunology
Total Addressable Market
$20 billion+
Red Tree Board Member(s)
Red Tree Board Observer
Heath Lukatch, Ph.D.
Affiliated with Red Tree SAB Member
Red Tree Participation
Co-investor in Series D
